268 related articles for article (PubMed ID: 19470783)
1. Nitric oxide-induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1.
Kitazawa T; Semba S; Huh YH; Kitazawa K; Eto M
J Physiol; 2009 Jul; 587(Pt 14):3587-603. PubMed ID: 19470783
[TBL] [Abstract][Full Text] [Related]
2. Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.
Dimopoulos GJ; Semba S; Kitazawa K; Eto M; Kitazawa T
Circ Res; 2007 Jan; 100(1):121-9. PubMed ID: 17158339
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MLC20 phosphorylation downstream of Ca2+ and RhoA: A novel mechanism involving phosphorylation of myosin phosphatase interacting protein (M-RIP) by PKG and stimulation of MLC phosphatase activity.
Mahavadi S; Nalli A; Al-Shboul O; Murthy KS
Cell Biochem Biophys; 2014 Jan; 68(1):1-8. PubMed ID: 23723008
[TBL] [Abstract][Full Text] [Related]
4. Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells.
Woodsome TP; Polzin A; Kitazawa K; Eto M; Kitazawa T
J Cell Sci; 2006 May; 119(Pt 9):1769-80. PubMed ID: 16608882
[TBL] [Abstract][Full Text] [Related]
5. cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase.
Nakamura K; Koga Y; Sakai H; Homma K; Ikebe M
Circ Res; 2007 Sep; 101(7):712-22. PubMed ID: 17673671
[TBL] [Abstract][Full Text] [Related]
6. Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation.
Qi F; Ogawa K; Tokinaga Y; Uematsu N; Minonishi T; Hatano Y
Anesth Analg; 2009 Aug; 109(2):412-7. PubMed ID: 19608811
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle.
Kitazawa T; Eto M; Woodsome TP; Khalequzzaman M
J Physiol; 2003 Feb; 546(Pt 3):879-89. PubMed ID: 12563012
[TBL] [Abstract][Full Text] [Related]
8. Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo.
Mizuno Y; Isotani E; Huang J; Ding H; Stull JT; Kamm KE
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C358-64. PubMed ID: 18524939
[TBL] [Abstract][Full Text] [Related]
9. Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle.
Woodsome TP; Eto M; Everett A; Brautigan DL; Kitazawa T
J Physiol; 2001 Sep; 535(Pt 2):553-64. PubMed ID: 11533144
[TBL] [Abstract][Full Text] [Related]
10. Convergence of Ca2+-desensitizing mechanisms activated by forskolin and phenylephrine pretreatment, but not 8-bromo-cGMP.
Porter M; Evans MC; Miner AS; Berg KM; Ward KR; Ratz PH
Am J Physiol Cell Physiol; 2006 Jun; 290(6):C1552-9. PubMed ID: 16421202
[TBL] [Abstract][Full Text] [Related]
11. Myosin phosphatase target subunit 1 (MYPT1) regulates the contraction and relaxation of vascular smooth muscle and maintains blood pressure.
Qiao YN; He WQ; Chen CP; Zhang CH; Zhao W; Wang P; Zhang L; Wu YZ; Yang X; Peng YJ; Gao JM; Kamm KE; Stull JT; Zhu MS
J Biol Chem; 2014 Aug; 289(32):22512-23. PubMed ID: 24951589
[TBL] [Abstract][Full Text] [Related]
12. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility.
Kitazawa T; Eto M; Woodsome TP; Brautigan DL
J Biol Chem; 2000 Apr; 275(14):9897-900. PubMed ID: 10744661
[TBL] [Abstract][Full Text] [Related]
13. Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation.
Etter EF; Eto M; Wardle RL; Brautigan DL; Murphy RA
J Biol Chem; 2001 Sep; 276(37):34681-5. PubMed ID: 11461918
[TBL] [Abstract][Full Text] [Related]
14. Actions downstream of cyclic GMP/protein kinase G can reverse protein kinase C-mediated phosphorylation of CPI-17 and Ca²⁺ sensitization in smooth muscle.
Bonnevier J; Arner A
J Biol Chem; 2004 Jul; 279(28):28998-9003. PubMed ID: 15123611
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of RhoA-dependent pathway and contraction by endogenous hydrogen sulfide in rabbit gastric smooth muscle cells.
Nalli AD; Rajagopal S; Mahavadi S; Grider JR; Murthy KS
Am J Physiol Cell Physiol; 2015 Mar; 308(6):C485-95. PubMed ID: 25567809
[TBL] [Abstract][Full Text] [Related]
16. Effects of eupatilin on the contractility of corpus cavernosal smooth muscle through nitric oxide-independent pathways.
Choo SH; Lee SW; Chae MR; Kang SJ; Sung HH; Han DH; Chun JN; Park JK; Kim CY; Kim HK; So I
Andrology; 2017 Sep; 5(5):1016-1022. PubMed ID: 28719725
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane A2-induced bi-directional regulation of cerebral arterial tone.
Neppl RL; Lubomirov LT; Momotani K; Pfitzer G; Eto M; Somlyo AV
J Biol Chem; 2009 Mar; 284(10):6348-60. PubMed ID: 19095646
[TBL] [Abstract][Full Text] [Related]
18. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway.
Aburima A; Walladbegi K; Wake JD; Naseem KM
J Thromb Haemost; 2017 Aug; 15(8):1668-1678. PubMed ID: 28509344
[TBL] [Abstract][Full Text] [Related]
19. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle.
Seko T; Ito M; Kureishi Y; Okamoto R; Moriki N; Onishi K; Isaka N; Hartshorne DJ; Nakano T
Circ Res; 2003 Mar; 92(4):411-8. PubMed ID: 12600888
[TBL] [Abstract][Full Text] [Related]
20. cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17.
Aslam M; Härtel FV; Arshad M; Gündüz D; Abdallah Y; Sauer H; Piper HM; Noll T
Cardiovasc Res; 2010 Jul; 87(2):375-84. PubMed ID: 20202976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
